H
Hangzhou Mandy Biotechnology
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C | 7 | 7.1 | 4.4 | 9.8 | 17 Nov 2025 |
| Tirzepatide | C | 7 | 5.9 | 4.9 | 7.8 | 25 Nov 2025 |
| 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | X | 1 | 6.3 | 6.3 | 6.3 | 20 Jun 2025 |
| ACE-031 | X | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 |
| Alprostadil | X | 1 | 7.6 | 7.6 | 7.6 | 3 Jul 2025 |
| Anadrol (Oxymetholone) | X | 1 | 8.5 | 8.5 | 8.5 | 20 Jun 2025 |
| Anastrozole (Arimidex) Raw | X | 1 | 8.7 | 8.7 | 8.7 | 2 Apr 2025 |
| Arimidex (Anastrozole) | X | 1 | 6.5 | 6.5 | 6.5 | 6 May 2025 |
| Benzaldehyde CAS 100-52-7 | X | 1 | 5.8 | 5.8 | 5.8 | 3 Jul 2025 |
| Botulinum toxin | X | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 |
| BPC157 10mg + TB500 10mg Blend | X | 1 | 8.9 | 8.9 | 8.9 | 28 Mar 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X | 1 | 7.8 | 7.8 | 7.8 | 2 Apr 2025 |
| Dapoxetine | X | 1 | 4.8 | 4.8 | 4.8 | 2 Jul 2025 |
| DHB (1-Test Cyp) | X | 1 | 5.5 | 5.5 | 5.5 | 24 Apr 2025 |
| EPO | X | 1 | 7.3 | 7.3 | 7.3 | 11 Jun 2025 |
| GHRP-2 Acetate | X | 1 | 8.5 | 8.5 | 8.5 | 13 Feb 2025 |
| GW-501516 (Cardarine) | X | 1 | 7.6 | 7.6 | 7.6 | 3 Jun 2025 |
| Halotestin (Fluoxymesterone) | X | 1 | 7.5 | 7.5 | 7.5 | 2 Apr 2025 |
| HMG | X | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 |
| Humanin | X | 1 | 5.5 | 5.5 | 5.5 | 8 Jul 2025 |
| Hyaluronic acid | X | 1 | 5.4 | 5.4 | 5.4 | 17 Dec 2024 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 6.5 | 6.5 | 6.5 | 28 Mar 2025 |
| MGF | X | 1 | 6.2 | 6.2 | 6.2 | 8 Jul 2025 |
| MT-1 | X | 1 | 6.5 | 6.5 | 6.5 | 9 Jun 2025 |
| NAD+ | X | 1 | 5.1 | 5.1 | 5.1 | 28 Mar 2025 |
| PE 22-28 | X | 1 | 6.7 | 6.7 | 6.7 | 3 Jun 2025 |
| PEG MGF | X | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 |
| Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 | X | 1 | 5.2 | 5.2 | 5.2 | 20 Jun 2025 |
| Selank 10mg + Semax 10mg Blend | X | 1 | 9.1 | 9.1 | 9.1 | 25 Apr 2025 |
| Selank | X | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 |
| Telmisartan | X | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 |
| Test Base (No Ester) | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 |
| Winstrol (Stanozolol) | X | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | GW-501516 (Cardarine) | 7.7 | 100mg | 100.4mg | +0.4% | 97.16% | Lab F |
| 24 May 2026 | Tirzepatide | 5.3 | 10mg | 10.2mg | +2.0% | 98.31% | No Label / Silver Crimp / Yellow Cap |
| 24 May 2026 | Benzaldehyde CAS 100-52-7 | 5.7 | 10g | 11.8g | +17.7% | 97.10% | Lab D |
| 24 May 2026 | Retatrutide | 6.6 | 10mg | 10.1mg | +1.0% | 99.28% | No Label / Silver Crimp / Green Cap |
| 24 May 2026 | Botulinum toxin | 8.8 | 15mg | 15.1mg | +0.8% | 96.89% | Lab G |
| 24 May 2026 | BPC157 10mg + TB500 10mg Blend | 9.0 | 20mg | 23.8mg | +19.0% | 99.11% | Lab E |
| 24 May 2026 | MGF | 6.2 | 2mg | 2.1mg | +5.0% | 99.92% | Lab B |
| 24 May 2026 | 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | 7.8 | 1g | 1.0g | -1.7% | 97.97% | Lab A |
| 24 May 2026 | EPO | 6.0 | 20mg | 22.6mg | +12.9% | 99.29% | Lab G |
| 24 May 2026 | NAD+ | 5.4 | 50mg | 52.5mg | +5.0% | 99.40% | Lab A |
| 23 May 2026 | Tirzepatide | 4.9 | 30mg | 31.4mg | +4.7% | 93.01% | No Label / Silver Crimp / Black Cap |
| 23 May 2026 | Anadrol (Oxymetholone) | 9.5 | 50mg | 60.2mg | +20.4% | 98.70% | Lab B |
| 23 May 2026 | Arimidex (Anastrozole) | 8.6 | 25mg | 22.6mg | -9.6% | 99.41% | Lab E |
| 23 May 2026 | GHRP-2 Acetate | 9.1 | 50mg | 47.9mg | -4.1% | 97.13% | Lab A |
| 20 May 2026 | Tirzepatide | 7.8 | 10mg | 9.55mg | -4.5% | 99.80% | No Label / Silver Crimp / White Cap |
| 20 May 2026 | Anastrozole (Arimidex) Raw | 7.7 | 100g | 85.0g | -15.0% | 95.07% | Lab B |
| 20 May 2026 | Hyaluronic acid | 5.7 | 50mg | 60.9mg | +21.9% | 95.36% | Lab F |
| 19 May 2026 | PE 22-28 | 6.9 | 50mg | 62.3mg | +24.6% | 98.51% | Lab E |
| 26 Jan 2026 | ACE-031 | 6.4 | 2mg | 1.7mg | -12.5% | 97.71% | Lab B |
| 26 Jan 2026 | Selank 10mg + Semax 10mg Blend | 8.2 | 2mg | 1.8mg | -10.4% | 98.02% | Lab C |
| 22 Jan 2026 | Retatrutide | 4.4 | 20mg | 29.7mg | +48.5% | 99.80% | White Label / Copper Crimp / Clear Cap |
| 19 Jan 2026 | Telmisartan | 6.4 | 20mg | 24.0mg | +19.9% | 96.10% | Lab B |
| 15 Jan 2026 | Tirzepatide | 4.9 | 40mg | 50.6mg | +26.5% | 99.90% | White Label / Silver Crimp / Red Cap |
| 15 Jan 2026 | Tirzepatide | 5.2 | 30mg | 34.9mg | +16.3% | 99.80% | No Label / Silver Crimp / Green Cap |
| 7 Jan 2026 | DHB (1-Test Cyp) | 4.4 | 200mg/ml | 179.5mg/ml | -10.3% | 98.22% | Lab A |
| 29 Dec 2025 | Selank | 9.5 | 50mg | 45.0mg | -9.9% | 96.90% | Lab B |
| 12 Dec 2025 | MT-1 | 5.1 | 2mg | 2.2mg | +11.8% | 99.41% | Lab B |
| 23 Nov 2025 | Halotestin (Fluoxymesterone) | 8.0 | 50mg | 49.6mg | -0.7% | 99.63% | Lab B |
| 23 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.0 | 30mg | 29.9mg | -0.4% | 95.87% | Lab G |
| 17 Nov 2025 | Test Base (No Ester) | 5.2 | 200mg/ml | 172.8mg/ml | -13.6% | 99.11% | Lab C |
| 14 Nov 2025 | HMG | 7.5 | 30mg | 26.0mg | -13.3% | 97.49% | Lab C |
| 5 Nov 2025 | Dapoxetine | 4.9 | 10mg | 8.7mg | -13.1% | 99.45% | Lab G |
| 4 Nov 2025 | Alprostadil | 4.0 | 15mg | 16.5mg | +10.1% | 98.25% | Lab G |
| 4 Nov 2025 | PEG MGF | 6.5 | 15mg | 16.7mg | +11.3% | 96.13% | Lab C |
| 17 Oct 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 9.0 | 10mg | 10.8mg | +7.5% | 95.21% | Lab A |
| 9 Oct 2025 | Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 | 4.5 | 10g | 10.8g | +8.0% | 98.99% | Lab G |
| 3 Oct 2025 | Humanin | 4.0 | 5mg | 5.6mg | +12.3% | 95.64% | Lab F |
| 3 Oct 2025 | Winstrol (Stanozolol) | 5.3 | 25mg | 25.4mg | +1.6% | 95.80% | Lab C |